Endoscopy

GI Dynamics, Inc. is to transition its EndoBarrier® Gastrointestinal Liner from clinical research status to commercial availability in Netherlands.

California-based Magnetecs Corporation has reported that the company’s Robotic Catheter Guidance Control and Imaging™ (CGCI) System has received CE Marking certification.

Tel Aviv University researcher proposes MRI-controllable capsule endoscope to investigate digestive system

Carl Zeiss Meditec bucks the trend with growth in all business areas and increased profitability.

US non-surgical obesity solutions company GI Dynamics, Inc. today announced that it has designated two new Centres of Excellence in Germany, bringing to three the number of specialist units offering the Endobarrier treatment in the country.

Smith and Nephew has recently combined its Orthopaedic and Trauma Business with its Endoscopy business and has now announced 80 job losses in Memphis Orthopaedic Division.

Olympus Corp’s board has signaled plans to quit over the much publicised $1.7 billion accounting fraud.

The tenth running of the Multidisciplinary European Endovascular Therapy (MEET) congress will be held in Rome on December 1st-3rd, at the Crowne Plaza St Peters Hotel.

BÂRRX Medical Inc., a leader in developing minimally invasive medical devices to remove precancerous tissue from the gastrointestinal tract, has announced today that it has signed a definitive agreement to be acquired by Covidien.

We summarise the sense of betrayal among Japanese Doctors who love Olympus but hate what it is being reported as doing.

Durable ePTFE Endoprosthesis Designed for Endovascular Repair of the Descending Thoracic Aorta Provides Conformability without Compromise

The Veith Vascular Symposium is taking place this week from November 16th to 20th in New York.

Ethicon Endo-Surgery, Inc. has announced U.S. FDA 510(k) clearance of its innovative ENSEAL® G2 Curved and Straight Tissue Sealers

Results from the COBRA clinical trial presented at TCT2011 show restenosis rate significantly reduced in diabetics when Cryoplasty adopted in SFA Stenting.

Researchers claim Transapical TAVR is “unattractive from a health economic perspective.” compared with femoral approach.

Smith & Nephew results for the third quarter show revenue increase, margin decrease and $150m cost reduction plans.